Ever Source Wealth Advisors, LLC Collegium Pharmaceutical, Inc Transaction History
Ever Source Wealth Advisors, LLC
- $1.65 Billion
- Q4 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 314 shares of COLL stock, worth $9,121. This represents 0.0% of its overall portfolio holdings.
Number of Shares
314
Previous 277
13.36%
Holding current value
$9,121
Previous $10,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding COLL
# of Institutions
247Shares Held
37.4MCall Options Held
59.3KPut Options Held
9.5K-
Black Rock Inc. New York, NY5.79MShares$168 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$76.7 Million1.45% of portfolio
-
Rubric Capital Management LP New York, NY2.35MShares$68.3 Million1.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$66.3 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.14MShares$62.2 Million0.15% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $991M
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...